Search

Your search keyword '"Lam, Wei-Sen"' showing total 24 results

Search Constraints

Start Over You searched for: Author "Lam, Wei-Sen" Remove constraint Author: "Lam, Wei-Sen"
24 results on '"Lam, Wei-Sen"'

Search Results

1. Biomarker-directed, pembrolizumab-based combination therapy in non-small cell lung cancer: phase 2 KEYNOTE-495/KeyImPaCT trial interim results

3. Durvalumab with first-line chemotherapy in previously untreated malignant pleural mesothelioma (DREAM): a multicentre, single-arm, phase 2 trial with a safety run-in

5. Feasibility of supervised telehealth exercise for patients with advanced melanoma receiving checkpoint inhibitor therapy

7. 635 KEYNOTE-495/KeyImPaCT: updated analysis of a biomarker-directed, randomized, phase 2 trial of pembrolizumab-based combination therapy for non-small cell lung cancer

8. Specialist pharmacist consultations with cancer patients in a pharmacist‐led anticancer clinic.

11. 457 KEYNOTE-495/KeyImPaCT: interim analysis of a randomized, biomarker-directed, phase 2 trial of pembrolizumab-based combination therapy for non–small cell lung cancer (NSCLC)

14. Increased interdigitation zone visibility on optical coherence tomography following systemic fibroblast growth factor receptor 1‐3 tyrosine kinase inhibitor anticancer therapy

15. Durvalumab with first-line chemotherapy in previously untreated malignant pleural mesothelioma (DREAM): a multicentre, single-arm, phase 2 trial with a safety run-in

16. A phase II trial of single oral FGF inhibitor, AZD4547, as second or third line therapy in malignant pleural mesothelioma

17. Final Results of the Dream Trial: A Phase 2 Trial of Durvalumab with First-Line Chemotherapy in Mesothelioma with a Safety Run-In

18. DREAM – a phase 2 trial of DuRvalumab with first line chEmotherApy in mesothelioma: final result

19. DREAM: A phase II study of durvalumab with first line chemotherapy in mesothelioma-First results

20. DREAM: A phase II study of durvalumab with first line chemotherapy in mesothelioma—First results.

24. Specialist pharmacist consultations with cancer patients in a pharmacist-led anticancer clinic.

Catalog

Books, media, physical & digital resources